ReviewFrontiers in immunology2021

P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target.

Silvere D Zaongo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.